HomeOwner SearchCategory Search
Visit USCOMacrolide Antibiotics Synthesis, Design, Modifications and Biological Evaluations Towards Potential Antibacterial Drug Research-design, Synthesis and Biological Evaluations of the Heterocycle-based Virginiamycin M2 Analogs and Enantioselective Synthetic Studies of the Core Moiety of Gulmirecin A
Text Registration
Copyright Title
Macrolide Antibiotics Synthesis, Design, Modifications and Biological Evaluations Towards Potential Antibacterial Drug Research-design, Synthesis and Biological Evaluations of the Heterocycle-based Virginiamycin M2 Analogs and Enantioselective Synthetic Studies of the Core Moiety of Gulmirecin A
Status
Published
on 25 Oct 2019
Year of Creation
2019
Copyright Claimant
Kaijie Ji
Registration Number
TX0008803372
on 25 Oct 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008803372) dated 25 Oct 2019, pertains to an electronic file (eService) titled "Macrolide Antibiotics Synthesis, Design, Modifications and Biological Evaluations Towards Potential Antibacterial Drug Research-design, Synthesis and Biological Evaluations of the Heterocycle-based Virginiamycin M2 Analogs and Enantioselective Synthetic Studies of the Core Moiety of Gulmirecin A" created in 2019. The copyright holder is Kaijie Ji, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Kaijie Ji.
Application Details
Registration Number
TX0008803372
Registration Date
10/25/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic Deposit
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Macrolide Antibiotics Synthesis, Design, Modifications and Biological Evaluations Towards Potential Antibacterial Drug Research-design, Synthesis and Biological Evaluations of the Heterocycle-based Virginiamycin M2 Analogs and Enantioselective Synthetic Studies of the Core Moiety of Gulmirecin A
Author Statement: Kaijie Ji Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.